KALV
KALV

Kalvista Pharmaceuticals Inc

NASDAQ · Biotechnology
$14.90
+0.50 (+3.47%)
Analyst Consensus
Strong Buy
15 analysts
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +334.6% upside
Low Target $35.35
Average Target $64.76
High Target $75.74
Current Price $14.90
Current
$14.90
Target
$64.76
$35.35 $64.76 avg $75.74